'Unprecedented' Plaque Clearance
Eisai Lymphoma Drug Reverses Alzheimer's Disease Symptoms
By Anette Breindl
Monday, February 13, 2012
Researchers identified a drug which, in animals, rapidly decreases both plaque area and soluble amyloid beta levels in mouse models of Alzheimer's disease. And it's FDA-approved.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.